pipette
ESEspañol

Equitable Access to GLP-1 Receptor Agonists—Essential but Not Accessible

Safura Abdool Karim, Ruth Faden, Chloe Searchinger, Thomas J. Bollyky

Peer-reviewed journalReal-world use

In the authors' words

This journal does not let us republish the full abstract. Here are the two sentences Pipette selected, quoted from it. Read the rest at the publisher.

Main result
This Perspective discusses the actions needed to improve accessibility of glucagon-like peptide-1 (GLP-1) receptor agonists, especially in low- and middle-income countries, after their addition to the World Health Organization’s (WHO) Model List of Essential Medicines.

Appeared: Saturday, October 3. JAMA. Peer-reviewed journal.

DOI: 10.1001/jama.2026.15762